Ashwagandha safety check in seniors: small study ends early
NCT ID NCT06171724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study aimed to measure how a standardized ashwagandha supplement is absorbed and tolerated in healthy adults aged 65 and older. Eleven participants took either 240 or 480 mg of the supplement, and researchers tracked levels of active compounds in the blood over 48 hours. The study was terminated early, so the findings are limited to basic safety and absorption data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ashwagandha (Withania somnifera) extract
What this could lead to
If successful, this could provide basic information on how ashwagandha is absorbed and tolerated in older adults, potentially guiding future studies on its health effects.
What could go wrong
This was a very small, early-phase study that was terminated, so results are limited. It only looked at safety and absorption, not whether ashwagandha has any health benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States